Related references
Note: Only part of the references are listed.Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells
Thomas Duhen et al.
BLOOD (2012)
Phenotypic and functional characteristics of CD4+CD39+FOXP3+ and CD4+CD39+FOXP3neg T-cell subsets in cancer patients
Patrick J. Schuler et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
AMP Is an Adenosine A1 Receptor Agonist
Joseph E. Rittiner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Ab initio study of MKrn2+(M = Cu, Ag, and Au, n=1-6) clusters
Xinying Li
JOURNAL OF MOLECULAR MODELING (2012)
Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions
Ayumi Yoshizaki et al.
NATURE (2012)
Lymph node choreography: B cells take the lead
Jennifer L. Cannons et al.
NATURE IMMUNOLOGY (2012)
A new paradigm for an old story: the role of regulatory B cells in cancer
Arya Biragyn et al.
FRONTIERS IN IMMUNOLOGY (2012)
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
Yohei Iwata et al.
BLOOD (2011)
Regulatory T Cells from IL-10-Deficient Mice Fail to Suppress Contact Hypersensitivity Reactions Due to Lack of Adenosine Production
Sabine Ring et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors-An Update
Bertil B. Fredholm et al.
PHARMACOLOGICAL REVIEWS (2011)
Generation and Accumulation of Immunosuppressive Adenosine by Human CD4+CD25highFOXP3+ Regulatory T Cells
Magis Mandapathil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Adenosine and Prostaglandin E2 Cooperate in the Suppression of Immune Responses Mediated by Adaptive Regulatory T Cells
Magis Mandapathil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Effector and regulatory B cells: modulators of CD4+ T cell immunity
Frances E. Lund et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis
Thomas Doerner et al.
AUTOIMMUNITY REVIEWS (2009)
Direct Expansion of Human Allospecific FoxP3+CD4+ Regulatory T Cells with Allogeneic B Cells for Therapeutic Application
Leo C. Chen et al.
JOURNAL OF IMMUNOLOGY (2009)
How Diverse-CD4 Effector T Cells and their Functions
Yisong Y. Wan et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2009)
Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells
Wenwei Tu et al.
BLOOD (2008)
Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis
David Saadoun et al.
BLOOD (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A(2A) receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells
Paul E. Zarek et al.
BLOOD (2008)
The frequency and suppressor function of CD4+CD25high Foxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck
Laura Strauss et al.
CLINICAL CANCER RESEARCH (2007)
Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis
P. P. Sfikakis et al.
CLINICAL IMMUNOLOGY (2007)
Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE
Therese Vallerskog et al.
CLINICAL IMMUNOLOGY (2007)
Primary T cell expansion and requires antigen presentation differentiation in vivo by B cells
Alison Crawford et al.
JOURNAL OF IMMUNOLOGY (2006)
Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study
Monica Vigna-Perez et al.
ARTHRITIS RESEARCH & THERAPY (2006)
B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ T cells:: Role of TGF-β1
VV Parekh et al.
JOURNAL OF IMMUNOLOGY (2003)